PinnedGrace Debeila·Jul 12, 2024Invest Like a Pro: Python-Powered Mean-Variance Portfolio Optimization with iShares Equity ETFsInvesting in a diversified portfolio of Exchange-Traded Funds (ETFs) has become increasingly popular among investors looking to balance…A response icon1A response icon1
PinnedInAI MindbyGrace Debeila·Aug 16, 2023Analysing Rand Sentiment in a Hashtag EconomyIn the vibrant realm of social media, where emoji’s tell tales and hashtags wield power, this article embarks on an enthralling expedition…
Grace Debeila·Jul 4, 2025Austrian Alpine Ascent: The Hills are Alive with the Sound of Alpha!In the grand orchestra of European equities, Austria rarely takes the conductor’s podium. Investors usually chase the bombast of German…
Grace Debeila·May 30, 2025Vital Signs Failing: UnitedHealth’s ICU Moment and a Grinold-Kroner DiagnosisUnitedHealth Group (NYSE: UNH), once the picture of robust health, has suffered a massive cardiac arrest. Down more than 40% year-to-date…
Grace Debeila·Mar 27, 2025Semiconductor Stunner: Scrutinising NVIDIA’s Stratospheric Returns with Grinold-Kroner ModelHouston, we have a puzzle!
Grace Debeila·Feb 22, 2025Web of Value: Weaving P/E-rfect Portfolios with Network TheoryIn today’s tech market, where giants like NVIDIA command breathtaking valuations, investors face a critical challenge: How do you separate…
Grace Debeila·Jan 11, 2025Beyond the Benchmark: Meandering through 2024’s Equity Market MazeThe global equity markets of 2024 presented themselves as an intricate maze, where traditional investment paths twisted into unexpected…
Grace Debeila·Dec 23, 2024Sip, Swirl & Strategize: A Yield Curve Sommelier’s Guide to the Art of Fixed Income Portfolio…QUANDOYEN — Bespoke Quantitative Expertise
Grace Debeila·Nov 22, 2024Novo Nordisk’s Trials and Tribulations: A Merton Model Prescription for Understanding the Risks…Having dissected Novo Nordisk’s liabilities in Part 2, we’re now ready to examine another vital sign in our Merton model checkup — the…
Grace Debeila·Nov 14, 2024Novo Nordisk’s Trials and Tribulations: A Merton Model Approach for Diagnosing the Risks (Part 2 of…As we dig deeper into Novo Nordisk’s financial health using the Merton model, it’s time to shine a light on the company’s debt schedule. In…